QQ客服 官方微博 反馈留言

	A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis
	Chen, Minjie; Gong, Lan; Sun, Xinghuai; Gu, Yangshun; He, Xiangge; Qu, Jia; Wang, Lili; Zhang, Mingzhi; Zhong, Xingwu
刊名	CURRENT MEDICAL RESEARCH AND OPINION
	2012
卷号	28期号:3
关键词	Blepharokeratoconjunctivitis Dexamethasone Intraocular pressure Loteprednol etabonate Safety Tobramycin
ISSN号	0300-7995
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4905606
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Chen, Minjie,Gong, Lan,Sun, Xinghuai,et al. A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis[J]. CURRENT MEDICAL RESEARCH AND OPINION,2012,28(3).
APA	Chen, Minjie.,Gong, Lan.,Sun, Xinghuai.,Gu, Yangshun.,He, Xiangge.,...&Zhong, Xingwu.(2012).A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis.CURRENT MEDICAL RESEARCH AND OPINION,28(3).
MLA	Chen, Minjie,et al."A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis".CURRENT MEDICAL RESEARCH AND OPINION 28.3(2012).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。